 The market capitalization of AIM stocks reached £103.4bn as of 27th January 2023, up 0.3% since the 13th of January 2023. Among the top YTD winners, there were Craven House Capital (up 311% YTD following the annual general meeting, Mkt cap of £1.2m), Genedrive Plc (+168% YTD), Ilika Plc (+147%), Inspecs Group (137%), Sound Energy (+100%), Genincode Plc (+100%). Among the bottom movers apart from canceling their admission to AIM Parsley Box, Joules Group and City of London Group (-62%), were also Inland Homes (-58% on selling strategic portfolio), IOG (-50%), Bluerock Diamonds (-50% on trading update), Frontier Developments Plc (-48.6%). Academic and educational services (+16.3% YTD weighted average), Basic Materials (+8.5%), Industrials (+7.7%), and Consumer Cyclicals (+7.1%) demonstrated better performance YTD, while Real Estate (-8.4% YTD) was the bottom performer.  Our top picks from the last screening demonstrated mixed performance. Renalytix was up 35% (on the news about the company and partners awarded a $10mn Horizon Europe Grant to advance treatment) between 13/01/23 and 27/01/23, while Sondrel was down 2%, Trident Royalties was 1% down, and Clean Power Hydrogen was 9% down.  Our screening list includes companies from the resources, technology equipment, and retail sectors. Our picks’ list includes SRT Marine Systems (a leading supplier of maritime domain awareness technologies, products, and systems), Likewise Group Plc (a distributor of floorcoverings and matting), Challenger Energy Plc ( an exploration and production business with assets in the Caribbean and Atlantic), Parkmead Group Plc (an independent energy group with assets in the UK and the Netherlands). Our choice is based on projected sales growth, comparable multiples, and recent performance. Companies are subject to AIM stock risks such as financial underperformance or stock dilutions in the future. We believe our top picks have an acceptable risk-return trade-off due to a sustainable product range or business model.